Cargando…
Genomic Grade Index predicts postoperative clinical outcome of GIST
BACKGROUND: Prognosis of localised gastrointestinal stromal tumour (GIST) is heterogeneous, notably for patients with AFIP intermediate or high risk of relapse, who are candidates to adjuvant imatinib. We hypothesised that gene expression profiles might improve the prognostication and help to refine...
Autores principales: | Bertucci, F, Finetti, P, Ostrowski, J, Kim, W K, Kim, H, Pantaleo, M A, Astolfi, A, Polkowski, M, Birnbaum, D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494448/ https://www.ncbi.nlm.nih.gov/pubmed/22929880 http://dx.doi.org/10.1038/bjc.2012.390 |
Ejemplares similares
-
CSPG4 Expression in GIST Is Associated with Better Prognosis and Strong Cytotoxic Immune Response
por: de Nonneville, Alexandre, et al.
Publicado: (2022) -
A seven-gene prognostic model for platinum-treated ovarian carcinomas
por: Sabatier, R, et al.
Publicado: (2011) -
Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice
por: Pantaleo, M A, et al.
Publicado: (2008) -
Targeted therapy in SDH-deficient GIST
por: Nannini, Margherita, et al.
Publicado: (2021) -
SDHA Germline Mutations in SDH-Deficient GISTs: A Current Update
por: Schipani, Angela, et al.
Publicado: (2023)